Skip to main content
. 2019 Nov 15;9:16928. doi: 10.1038/s41598-019-53294-z

Table 3.

Neuroinflammation markers, changes in mRNA and protein levels, and correlation between mRNA and protein expressions.

Sex Endpoint Marker Region Analysis Post-hoc compared to VV Protein-mRNA
Main effect: postnatal Interaction
Statistic (df) P value Statistic (df) P value
Male mRNA Iba-1 mPFC F(1,16) = 230.33 <0.0001 F(1,16) = 8.62 0.0097 VL, PL
AMY F(1,16) = 165.08 <0.0001 F(1,16) = 56.41 <0.0001 VL, PL
HP F(1,16) = 593.80 <0.0001 F(1,16) = 38.33 <0.0001 PV, VL, PL
TM F(1,16) = 232.03 <0.0001 F(1,16) = 1.43 ns VL, PL
GFAP mPFC F(1,16) = 474.33 <0.0001 F(1,16) = 59.83 <0.0001 VL, PL
AMY F(1,16) = 657.53 <0.0001 F(1,16) = 379.92 <0.0001 PV, VL, PL
HP F(1,16) = 917.53 <0.0001 F(1,16) = 13.15 0.0023 VL, PL
TM F(1,16) = 947.50 <0.0001 F(1,16) = 0.01 ns VL, PL
TSPO mPFC F(1,16) = 868.23 <0.0001 F(1,16) = 81.84 <0.0001 VL, PL
AMY F(1,16) = 733.73 <0.0001 F(1,16) = 364.60 <0.0001 PV, VL, PL
HP F(1,16) = 664.81 <0.0001 F(1,16) = 30.96 <0.0001 PV, VL, PL
TM F(1,16) = 470.88 <0.0001 F(1,16) = 363.57 <0.0001 PL
Female mRNA Iba-1 mPFC F(1,16) = 227.77 <0.0001 F(1,16) = 0.76 ns PV, VL, PL
AMY F(1,16) = 70.97 <0.0001 F(1,16) = 10.80 0.0046 PV, VL, PL
HP F(1,16) = 4.09 ns F(1,16) = 23.88 0.0002 PV, VL
TM F(1,16) = 50.14 <0.0001 F(1,16) = 0.92 ns VL, PL
GFAP mPFC F(1,16) = 299.84 <0.0001 F(1,16) = 113.53 <0.0001 PV, VL, PL
AMY F(1,16) = 16.11 0.001 F(1,16) = 0.14 ns
HP F(1,16) = 1.72 ns F(1,16) = 0.02 ns
TM F(1,16) = 0.08 ns F(1,16) = 0.07 ns
TSPO mPFC F(1,16) = 59.59 <0.0001 F(1,16) = 3.23 ns PV, VL, PL
AMY F(1,16) = 122.66 <0.0001 F(1,16) = 97.23 <0.0001 PV, VL, PL
HP F(1,16) = 7.16 0.0165 F(1,16) = 130.88 <0.0001 PV, VL, PL
TM F(1,16) = 0.01 ns F(1,16) = 2.14 ns PL
Male protein Iba-1 mPFC F(1,8) = 165.92 <0.0001 F(1,8) = 8.74 0.0182 PV, VL, PL R2 = 0.5748, P = 0.0043
AMY F(1,8) = 40.10 0.0002 F(1,8) = 34.41 0.0004 PV, VL, PL R2 = 0.7034, P = 0.0007
HP F(1,8) = 17.97 0.0028 F(1,8) = 5.80 0.0427 VL R2 = 0.5466, P = 0.006
TM F(1,8) = 108.06 <0.0001 F(1,8) = 0.09 ns VL, PL R2 = 0.5818, P = 0.0039
GFAP mPFC F(1,8) = 37.91 0.0003 F(1,8) = 6.12 0.0385 PV, VL, PL R2 = 0.3761, P = 0.034
AMY F(1,8) = 54.46 <0.0001 F(1,8) = 0.02 ns VL, PL R2 = 0.4205, P = 0.0226
HP F(1,8) = 53.09 <0.0001 F(1,8) = 8.80 0.018 PL R2 = 0.7659, P = 0.0002
TM F(1,8) = 65.20 <0.0001 F(1,8) = 28.48 0.0007 PV, VL, PL R2 = 0.7761, P = 0.0002
TSPO mPFC F(1,8) = 201.75 <0.0001 F(1,8) = 1.00 ns VL, PL R2 = 0.6421, P = 0.0017
AMY F(1,8) = 62.67 <0.0001 F(1,8) = 7.66 0.0244 VL, PL R2 = 0.6699, P = 0.0011
HP F(1,8) = 14.64 0.005 F(1,8) = 0.56 ns R2 = 0.2903, ns
TM F(1,8) = 105.84 <0.0001 F(1,8) = 3.01 ns VL, PL R2 = 0.7567, P = 0.0002
Female protein Iba-1 mPFC F(1,8) = 30.53 0.0006 F(1,8) = 0.02 ns VL, PL R2 = 0.3553, P = 0.0408
AMY F(1,8) = 50.77 <0.0001 F(1,8) = 0.90 ns VL, PL R2 = 0.3117, ns
HP F(1,8) = 0.07 ns F(1,8) = 6.09 0.0389 R2 = 0.0375, ns
TM F(1,8) = 67.45 <0.0001 F(1,8) = 0.78 ns VL, PL R2 = 0.6582, P = 0.0014
GFAP mPFC F(1,8) = 42.48 0.0002 F(1,8) = 33.15 0.0004 PL R2 = 0.2036, ns
AMY F(1,8) = 8.95 0.0173 F(1,8) = 0.25 ns R2 = 0.334, P = 0.0491
HP F(1,8) = 246.59 <0.0001 F(1,8) = 5.03 ns VL, PL R2 = 0.0032, ns
TM F(1,8) = 0.00 ns F(1,8) = 0.04 ns R2 = 0.0032, ns
TSPO mPFC F(1,8) = 2.07 ns F(1,8) = 0.66 ns R2 = 0.1452, ns
AMY F(1,8) = 2.61 ns F(1,8) = 2.08 ns R2 = 0.2999, ns
HP F(1,8) = 0.14 ns F(1,8) = 6.04 0.0394 R2 = 0.4028, P = 0.0266
TM F(1,8) = 0.10 ns F(1,8) = 0.24 ns R2 = 0.1575, ns

Statistical analysis of neuroinflammatory mRNA and protein markers by brain region for males and females. ns, not significant; VV, Vehicle-Vehicle; PV, Poly I:C-Vehicle; VL, Vehicle-LPS; PL, Poly I:C-LPS.